Overview: Mycobacterium Tuberculosis PCR TestIntroduction: The Mycobacterium Tuberculosis PCR Test detects Mycobacterium tuberculosis DNA to diagnose tuberculosis, causing cough or fever. Following 2023 WHO guidelines, it uses PCR for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in mycology for patients with suspected pulmonary or extrapulmonary tuberculosis.
Other Names: TB PCR Assay, Tuberculosis DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting mycology standards for diagnostic accuracy.
Historical Milestone: TB PCR testing began in the 1990s with molecular diagnostics research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Mycobacterium tuberculosis DNA to diagnose tuberculosis, guides treatment, and evaluates patients with cough or fever.
Test Parameters: 1. Mycobacterium Tuberculosis DNA
Pretest Condition: No fasting required. Collect sputum, bronchoalveolar lavage, whole blood, tissue, CSF, or saliva. Report history of cough, fever, or TB exposure.
Specimen: Sputum (sterile container, 5-10 mL), Bronchoalveolar Lavage (sterile container, 5-10 mL), Whole Blood (EDTA, 2-5 mL), Tissue (sterile container, 0.5-2 cma³), CSF (sterile container, 1-2 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document cough, fever, weight loss, or history of TB exposure. Include current medications, especially antitubercular drugs.
Consent: Written consent required, detailing the tests purpose, tuberculosis implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect Mycobacterium tuberculosis DNA in specimens. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for tuberculosis diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Positive Mycobacterium tuberculosis DNA confirms tuberculosis, guiding antitubercular therapy (e.g., rifampin). Negative results may require culture testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: AFB smear, TB culture, or chest X-ray to confirm tuberculosis diagnosis.
Test Limitations: Sensitivity depends on sample quality; clinical correlation is needed. False negatives may occur in low-burden disease.
References: WHO Tuberculosis Guidelines, 2023; The Lancet Infectious Diseases, Pai M, 2022.
